Wellbutrin XL™, a brand name for the extended release version of bupropion, a norepinephrine and dopamine reuptake inhibitor (NDRI) used to treat major depressive disorder, including seasonal affective disorder (SAD).
| Reasons taken | # of patients | Major | Moderate | Slight | None | Can’t tell | # of patients evaluated by |
|---|---|---|---|---|---|---|---|
| Treat my mood condition(s) | 98 |
|
|
|
|
21 | |
| Depression | 62 |
|
|
|
|
|
21 |
| Bipolar Disorder | 18 |
|
|
|
6 | ||
| Support another treatment | 7 |
|
|
|
3 | ||
| Anxiety | 7 |
|
|
3 | |||
| Major Depressive Disorder | 6 |
|
1 |
See all 168 patients currently taking Wellbutrin XL
Mouse over the table for more information
Top 10 dosages based on patients currently taking Wellbutrin XL. See all 14 dosages ►
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
|
Side effects too severe
|
18 | 42% |
|
|
Did not seem to work
|
17 | 40% |
|
|
Doctor's advice
|
14 | 33% |
|
|
Other
|
10 | 23% |
|
|
Expense
|
4 | 9% |
|
|
Personal research
|
2 | 5% |
|
|
Course of treatment ended
|
1 | 2% |
|
|
Not indicated
|
1 | 2% |
|
See more information, including instructions, precautions, side effects, and interactions.
Report created on November 22, 2009.